ArticleBMC cancer2025

Study protocol of a randomised phase II trial of concurrent stereotactic body radiotherapy with immunotherapy versus immunotherapy alone in patients with 1-5 extracranial melanoma oligometastases (AXIOM).

Angela M Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.